Skip to main content

Incannex Healthcare Inc ADR(IXHL-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.69
Day High3.05
Open:2.97
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
Incannex preparing psilocybin therapy FDA IND application
TheNewswire.com
Incannex full steam ahead towards sleep apnoea trial
TheNewswire.com
Incannex thrilled with positive pre-IND meeting for arthritis treatment
TheNewswire.com
Incannex appoints CRO ahead of Phase 2/3 sleep apnoea trial
TheNewswire.com
Incannex CEO talks plans to redomicile to US
TheNewswire.com
Incannex appoints principal investigators for pivotal IHL-42X trial
TheNewswire.com
Incannex welcomes world-leading psychedelics experts to advisory board
TheNewswire.com
Incannex readying for Phase 2 clinical trial of anti-inflammatory drug IHL-675A
TheNewswire.com
Incannex to work with Catalent to produce psilocybin for clinical and potentially commercial use
TheNewswire.com
Incannex Healthcare kicks off Phase 2 rheumatoid arthritis trial
PR Newswire
Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A
PR Newswire
Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement
PR Newswire
Incannex to Present at the H.C. Wainwright First Annual Mental Health Conference

Profile

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.